Clinical trial
Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia…
NCT00464243 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00464243 |
|---|---|
| Title | Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study |
| Official title | Efficacy and Safety of 2 mg/Day M100907 on Sleep Maintenance Insomnia: a 6-week, Multicenter, Randomized, Double-blind, Placebo-controlled Polysomnographic Study |
| Acronym | NOCTURNE907 |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders |
| Intervention type | Drug |
| Interventions | volinanserin, placebo |
| Enrollment | 604 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Apr 23, 2007 |
| Last update posted | Aug 8, 2017 |
| Countries | Australia, Austria, Canada, France, Germany, Russia, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: